HealthStream Promotes Michael M. Collier to Chief Operating Officer
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 6 days ago
0mins
Should l Buy HSTM?
HealthStream announced the promotion of Michael M. Collier from Executive Vice President to Chief Operating Officer (COO) & Executive Vice President. In this expanded role, Mr. Collier will lead enterprise operations across HealthStream, including customer experience functions, corporate development and mergers and acquisitions, implementations, legal, human resources, partnerships, business enablement, and other critical areas. He will also serve as executive sponsor for the Company's AI transformation, driving AI readiness across operational teams and advancing the use of AI to support the workforce and internal business processes. Since joining HealthStream in 2011 as a corporate attorney, Mr. Collier has advanced through roles of increasing responsibility and has been instrumental in the Company's growth, including leading more than two dozen successful acquisitions.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy HSTM?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on HSTM
Wall Street analysts forecast HSTM stock price to rise
4 Analyst Rating
2 Buy
2 Hold
0 Sell
Moderate Buy
Current: 23.960
Low
25.00
Averages
25.00
High
25.00
Current: 23.960
Low
25.00
Averages
25.00
High
25.00
About HSTM
HealthStream, Inc. provides platform-delivered workforce solutions. Its solutions include Software-as-a-Service (SaaS), subscription-based applications used by healthcare organizations to meet a range of their workforce development needs around learning, clinical development, credentialing, and scheduling. Its content libraries allow customers to subscribe to an array of courseware, which includes content from healthcare and nursing associations, medical and healthcare publishers, and other content providers. Its scheduling solutions provide customers with real-time visibility into clinical staff scheduling. Its credentialing, privileging, and enrollment solution, CredentialStream, provides customers a user experience with a continual stream of enhancements, evidence-based content, and curated data, which provides healthcare organizations with tools to support the provider lifecycle management from recruiting, application submission, verification of licensure, and other credentials.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
HealthStream Reports Record Q1 2026 Revenue and EBITDA
- Record Financial Performance: HealthStream achieved record revenues of $81.2 million and adjusted EBITDA of $20.1 million in Q1 2026, reflecting strong financial growth that enhances its market position in the healthcare technology sector.
- Expanded Investment Plans: The robust performance in Q1 has prompted management to increase investments beyond original plans, particularly in growth initiatives related to current products, upcoming new products, and accelerated AI applications, aimed at improving overall operational efficiency.
- Significant Acquisition Contributions: Two acquisitions contributed $3.4 million in revenue during Q1, with integration progressing well, indicating the effectiveness of the company's strategy in expanding market reach and enhancing service capabilities.
- Optimistic Future Outlook: Management reaffirmed full-year 2026 revenue guidance of $323 million to $330 million, with an expected revenue growth rate of approximately 9.5% for Q2, demonstrating confidence in future growth and sustained market demand.
See More
HealthStream Declares Quarterly Dividend of $0.035
- Quarterly Dividend Declaration: HealthStream has declared a quarterly dividend of $0.035 per share, consistent with previous distributions, indicating the company's stable cash flow and profitability, which is likely to attract more investor interest.
- Dividend Yield: The forward yield of 0.66% reflects the company's robust performance in the current market environment, potentially enhancing shareholder confidence and stabilizing the stock price.
- Shareholder Record Date: The dividend will be payable on May 29, with a record date of May 18 and an ex-dividend date also on May 18, providing investors with a clear timeline for their investment decisions.
- 2026 Revenue Target: HealthStream has outlined a revenue target of $323 million to $330 million for 2026, demonstrating the company's strategic commitment to advancing its AI-enabled platform and ecosystem, which is expected to drive future growth potential.
See More
HealthStream Reports Q1 Earnings Growth
- Profitability Improvement: HealthStream's Q1 net income reached $5.91 million, translating to an EPS of $0.20, which marks a significant increase from last year's $4.33 million and $0.14, reflecting enhanced competitiveness in the market.
- Significant Revenue Growth: The company's revenue rose by 10.5% year-over-year to $81.20 million, up from $73.49 million last year, indicating a strong performance in customer demand and market share.
- Full-Year Revenue Guidance: HealthStream projects full-year revenue between $323 million and $330 million, demonstrating management's confidence in future performance, which is expected to further bolster the company's market position in the healthcare sector.
- Positive Market Reaction: With the earnings improvement, investor confidence in HealthStream is likely to increase, which is expected to have a positive impact on the company's stock price and further solidify its leadership in the healthcare services field.
See More
HealthStream Q1 Earnings Exceed Expectations
- Strong Earnings Report: HealthStream's Q1 GAAP EPS of $0.20 beats expectations by $0.04, indicating a sustained improvement in profitability and reflecting the company's robust performance in the healthcare sector.
- Revenue Growth: The company reported Q1 revenue of $81.2 million, a 10.5% year-over-year increase, surpassing market expectations by $1.52 million, demonstrating strong performance amid rising market demand.
- Adjusted EBITDA Increase: Adjusted EBITDA reached $20.1 million, up 24.1% from $16.2 million in Q1 2025, showcasing significant improvements in cost control and operational efficiency.
- Shareholder Return Initiatives: The Board declared a quarterly cash dividend of $0.035 per share and authorized a share repurchase program of up to $10 million, aimed at enhancing shareholder value and reflecting confidence in future growth.
See More
HealthStream Reports Record Q1 2026 Results with 10.5% Revenue Growth
- Significant Revenue Growth: HealthStream's Q1 revenue reached $81.2 million, marking a 10.5% increase from $73.5 million in Q1 2025, setting a new record for quarterly revenue and demonstrating strong market demand in the healthcare technology sector.
- Substantial Operating Income Increase: The operating income for Q1 was $7.5 million, up 71.6% from $4.4 million in Q1 2025, primarily driven by increased revenues and sublease income, reflecting effective strategies in cost control and revenue growth.
- Net Income and EPS Growth: The net income for Q1 was $5.9 million, a 36.4% increase year-over-year, with earnings per share (EPS) at $0.20, up from $0.14 in Q1 2025, indicating enhanced profitability and improved shareholder returns.
- Share Repurchase and Dividend Policy: The company announced a share repurchase program of up to $10 million and declared a quarterly cash dividend of $0.035 per share payable on May 29, 2026, reflecting confidence in future growth and commitment to shareholders.
See More
HealthStream Schedules Q1 2026 Earnings Call and Webcast
- Earnings Release Schedule: HealthStream will release its Q1 2026 financial results after market close on May 4, 2026, ensuring timely access to crucial financial information for investors and enhancing market transparency.
- Conference Call Timing: The earnings call is scheduled for May 5, 2026, at 9:00 a.m. Eastern Time, aimed at providing an in-depth discussion of financial performance, thereby improving investor relations management.
- Participation Method: Investors can join the call via webcast or telephone, with advance registration required to obtain dial-in details, ensuring smooth access for participants and enhancing engagement during the call.
- Replay Availability: A replay of the call will be archived on the company's website for at least 30 days post-event, allowing investors who could not attend live to access the information, further increasing the accessibility and transparency of corporate communications.
See More
HealthStream Reports Record Q1 2026 Revenue and EBITDA
- Record Financial Performance: HealthStream achieved record revenues of $81.2 million and adjusted EBITDA of $20.1 million in Q1 2026, reflecting strong financial growth that enhances its market position in the healthcare technology sector.
- Expanded Investment Plans: The robust performance in Q1 has prompted management to increase investments beyond original plans, particularly in growth initiatives related to current products, upcoming new products, and accelerated AI applications, aimed at improving overall operational efficiency.
- Significant Acquisition Contributions: Two acquisitions contributed $3.4 million in revenue during Q1, with integration progressing well, indicating the effectiveness of the company's strategy in expanding market reach and enhancing service capabilities.
- Optimistic Future Outlook: Management reaffirmed full-year 2026 revenue guidance of $323 million to $330 million, with an expected revenue growth rate of approximately 9.5% for Q2, demonstrating confidence in future growth and sustained market demand.
See More
HealthStream Declares Quarterly Dividend of $0.035
- Quarterly Dividend Declaration: HealthStream has declared a quarterly dividend of $0.035 per share, consistent with previous distributions, indicating the company's stable cash flow and profitability, which is likely to attract more investor interest.
- Dividend Yield: The forward yield of 0.66% reflects the company's robust performance in the current market environment, potentially enhancing shareholder confidence and stabilizing the stock price.
- Shareholder Record Date: The dividend will be payable on May 29, with a record date of May 18 and an ex-dividend date also on May 18, providing investors with a clear timeline for their investment decisions.
- 2026 Revenue Target: HealthStream has outlined a revenue target of $323 million to $330 million for 2026, demonstrating the company's strategic commitment to advancing its AI-enabled platform and ecosystem, which is expected to drive future growth potential.
See More
HealthStream Reports Q1 Earnings Growth
- Profitability Improvement: HealthStream's Q1 net income reached $5.91 million, translating to an EPS of $0.20, which marks a significant increase from last year's $4.33 million and $0.14, reflecting enhanced competitiveness in the market.
- Significant Revenue Growth: The company's revenue rose by 10.5% year-over-year to $81.20 million, up from $73.49 million last year, indicating a strong performance in customer demand and market share.
- Full-Year Revenue Guidance: HealthStream projects full-year revenue between $323 million and $330 million, demonstrating management's confidence in future performance, which is expected to further bolster the company's market position in the healthcare sector.
- Positive Market Reaction: With the earnings improvement, investor confidence in HealthStream is likely to increase, which is expected to have a positive impact on the company's stock price and further solidify its leadership in the healthcare services field.
See More
HealthStream Q1 Earnings Exceed Expectations
- Strong Earnings Report: HealthStream's Q1 GAAP EPS of $0.20 beats expectations by $0.04, indicating a sustained improvement in profitability and reflecting the company's robust performance in the healthcare sector.
- Revenue Growth: The company reported Q1 revenue of $81.2 million, a 10.5% year-over-year increase, surpassing market expectations by $1.52 million, demonstrating strong performance amid rising market demand.
- Adjusted EBITDA Increase: Adjusted EBITDA reached $20.1 million, up 24.1% from $16.2 million in Q1 2025, showcasing significant improvements in cost control and operational efficiency.
- Shareholder Return Initiatives: The Board declared a quarterly cash dividend of $0.035 per share and authorized a share repurchase program of up to $10 million, aimed at enhancing shareholder value and reflecting confidence in future growth.
See More
HealthStream Reports Record Q1 2026 Results with 10.5% Revenue Growth
- Significant Revenue Growth: HealthStream's Q1 revenue reached $81.2 million, marking a 10.5% increase from $73.5 million in Q1 2025, setting a new record for quarterly revenue and demonstrating strong market demand in the healthcare technology sector.
- Substantial Operating Income Increase: The operating income for Q1 was $7.5 million, up 71.6% from $4.4 million in Q1 2025, primarily driven by increased revenues and sublease income, reflecting effective strategies in cost control and revenue growth.
- Net Income and EPS Growth: The net income for Q1 was $5.9 million, a 36.4% increase year-over-year, with earnings per share (EPS) at $0.20, up from $0.14 in Q1 2025, indicating enhanced profitability and improved shareholder returns.
- Share Repurchase and Dividend Policy: The company announced a share repurchase program of up to $10 million and declared a quarterly cash dividend of $0.035 per share payable on May 29, 2026, reflecting confidence in future growth and commitment to shareholders.
See More
HealthStream Schedules Q1 2026 Earnings Call and Webcast
- Earnings Release Schedule: HealthStream will release its Q1 2026 financial results after market close on May 4, 2026, ensuring timely access to crucial financial information for investors and enhancing market transparency.
- Conference Call Timing: The earnings call is scheduled for May 5, 2026, at 9:00 a.m. Eastern Time, aimed at providing an in-depth discussion of financial performance, thereby improving investor relations management.
- Participation Method: Investors can join the call via webcast or telephone, with advance registration required to obtain dial-in details, ensuring smooth access for participants and enhancing engagement during the call.
- Replay Availability: A replay of the call will be archived on the company's website for at least 30 days post-event, allowing investors who could not attend live to access the information, further increasing the accessibility and transparency of corporate communications.
See More
